Sicad, Angel .
HRN: 00-12-34 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/03/2023
CO-AMOXICLAV 625MG (TAB)
10/03/2023
10/10/2023
PO
625 Mg
BID
PROM X 17 Hours
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes